Projects per year
Organisation profile
Organisation profile
The Unit facilitates the development of powerful working groups who have had considerable success in gaining EU-based external funding, and producing high-impact research.
The Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit has a close connection, some shared membership and interests with the Medicinal and Analytical Chemistry Group (MACG), particularly in respect of NPS and natural products.
Research areas
The Unit has carried out research projects in a range of areas, including:
- Epidemiology of drug misuse, including drug mortality and 'near misses', and associated indicators
- Pharmacovigilance/toxicovigilance approaches in assessing the abuse potential of prescription and 'over the counter' drugs
- Web-based studies of Novel Psychoactive Substances (NPS) and traditional drugs
- Deep web; dark net; and NPS trading
- NPS and preclinical pharmacological issues
- Analytical chemistry issues relating to NPS
- Performance- and Image-Enhancing (PIEDs; lifestyle drugs) drugs’ misuse
Fingerprint
Dive into the research topics where Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Dr Michelle Botha
- Centre for Health Services and Clinical Research
- Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
- Department of Clinical, Pharmaceutical and Biological Science
- Centre for Research in Mechanisms of Disease and Drug Discovery
- School of Life and Medical Sciences
Person: Academic
-
Professor Ornella Corazza
- Department of Clinical, Pharmaceutical and Biological Science
- Centre for Health Services and Clinical Research
- Centre for Future Societies Research
- Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
- School of Life and Medical Sciences
Person: Academic Manager, Academic
-
Development and Characterization of a Duckweed-Based Biostimulant (DWEBS) for Enhanced Crop Growth and Stress Resistance
Barrero Sicilia, C. (PI) & Stair, J. (CoI)
9/09/24 → 8/09/25
Project: Research
-
Bootstrap: Boosting Societal Adaptation and Mental Health in a Rapidly Digitalising, Post-Pandemic Europe
Fineberg, N. (PI), Wellsted, D. (CoI), Trivedi, D. (CoI), Jones, J. (CoI), Pellegrini, L. (CoI), Corazza, O. (CoI) & Hall, N. (CoI)
1/07/23 → 30/06/28
Project: Research
-
BUV Wales : Evaluation of the introduction and effectiveness of Buvidal across Wales
Schifano, F. (PI)
1/06/23 → 31/07/25
Project: Research
-
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data
Chiappini, S., Mosca, A., Papanti, D. G., Corkery, J. M., Guirguis, A., Arillotta, D., Martinotti, G. & Schifano, F., 15 May 2025, In: Journal of Clinical Medicine (JCM). 14, 10, p. 1-11 11 p., 3461.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The phenomenology of psilocybin: transformative insights for research and clinical practice
Metastasio, A., Prevete, E., Venturini, S., Garofalo, A., Cecconello, B., De Pisapia, N. & Corazza, O., 25 Apr 2025, (E-pub ahead of print) In: Frontiers in Psychology. 16, p. 1-12 12 p., 1455902.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
Schifano, F., Bonaccorso, S., Arillotta, D., Guirguis, A., Corkery, J. M., Floresta, G., Papanti Pelletier, G. D., Scherbaum, N., Schifano, N. & Zhou, Y. (Editor), 22 Apr 2025, In: Brain Sciences. 15, 5, p. 1-14 14 p., 424.Research output: Contribution to journal › Review article › peer-review
Open AccessFile1 Downloads (Pure)